Please login to the form below

Not currently logged in
Email:
Password:

New Accounts, July, 2009, PR & Med Ed

New pharmaceutical account wins notified to us by the winning agency for the period May 2009 and July 2009 inclusive

New pharmaceutical account wins notified to us by the winning agency for the period May 2009 and July 2009 inclusive:

 

CLIENT

PRODUCT

THERAPEUTIC AREA

WINNING AGENCY

AstraZeneca
N/A
Non-small cell lung cancer
Medaxial Group
AZ/BMSOnglyzaDiabetes Virgo HEALTH
AlmirallSolarazeDermatologySignature Healthcare Communications
Biogen Idec
N/A
Neurology
Medaxial Group
BMSPatient support HIVHive
Boehringer IngelheimCMENon-small cell lung cancerStrategic Consultants International
The Hesley GroupN/ACorporateClew Communications
Cranage Healthcare InternationalNew productDermatologySignature Healthcare Communications
GaldermaNew productDermatologySignature Healthcare Communications
GSK
Cervarix
Cervical cancer
Virgo HEALTH
IDIS
European and  UK corporate
Corporate
Ogilvy Healthworld UK
MundipharmaStrategic planning processes and European internal comms engagement CorporateJYC Global
Napp PharmaceuticalsOxycontinPalliative CareSignature Healthcare Communications
NovartisNHS engagementDiabetes, Hypertension, CVJYC Global
Nutricia Advanced Medical Nutrition
Respifor
COPD
Virgo HEALTH
Nutricia Advanced Medical NutritionConference support
Cross-brand
Virgo HEALTH
Orchid
Male cancer awareness week
Corporate
Spink
Schering-Plough
NHS project work
Cardiovascular
JYC Global
SKCINCorporateSkin cancer
Signature Healthcare Communications


Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets.

To submit an entry for New Accounts, email new_accounts@pmlive.com

29th July 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
PRMA Consulting Ltd

PRMA Consulting is an independent consultancy solving some of the most challenging pricing, reimbursement and market access issues facing international...

Latest intelligence

Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...
Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...

Infographics